Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$1.06 - $1.67 $11,130 - $17,535
-10,500 Reduced 51.22%
10,000 $11,000
Q4 2023

Feb 05, 2024

SELL
$1.26 - $1.79 $8,820 - $12,530
-7,000 Reduced 25.45%
20,500 $34,000
Q3 2023

Oct 10, 2023

BUY
$1.61 - $2.54 $20,125 - $31,750
12,500 Added 83.33%
27,500 $49,000
Q2 2023

Jul 19, 2023

BUY
$1.14 - $1.95 $17,100 - $29,250
15,000 New
15,000 $27,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.